Home>>GGACK (H-Glu-Gly-Arg-chloromethylketone)

GGACK (H-Glu-Gly-Arg-chloromethylketone) Sale

(Synonyms: 精氨酸杂质) 目录号 : GA22381 复制 一键复制产品信息

GGACK (H-Glu-Gly-Arg-chloromethylketone) 是一种不可逆的丝氨酸蛋白酶抑制剂,GGACK可抑制尿激酶型纤溶酶原激活剂(uPA)并阻断纤溶酶原激活过程。

GGACK (H-Glu-Gly-Arg-chloromethylketone) Chemical Structure

Cas No.:65113-67-9

规格 价格 库存 购买数量
1mg
¥1,440.00
现货
5mg
¥3,600.00
现货
10mg
¥5,400.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

加载文献引用…

Description

GGACK (H-Glu-Gly-Arg-chloromethylketone) is an irreversible serine protease inhibitor. GGACK can inhibit urokinase-type plasminogen activator (uPA) and block the plasminogen activation process. GGACK can be used for research related to cancer and coagulation-related diseases[1].

GGACK (10-100nM) had been used to treat PMA-stimulated U-937 leukemia cells for 30 minutes to induce high expression of uPAR, after which fluorescently labeled HMW-uPA was added. GGACK competitively inhibited the binding of HMW-uPA to the cell surface uPAR receptors[2].

References:
[1] Sperl S, Jacob U, Arroyo de Prada N, et al. (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5113-8.
[2] De Souza M, Matthews H, Lee JA, et al. Small molecule antagonists of the urokinase (uPA): urokinase receptor (uPAR) interaction with high reported potencies show only weak effects in cell-based competition assays employing the native uPAR ligand. Bioorg Med Chem. 2011 Apr 15;19(8):2549-56.

GGACK (H-Glu-Gly-Arg-chloromethylketone) 是一种不可逆的丝氨酸蛋白酶抑制剂,GGACK可抑制尿激酶型纤溶酶原激活剂(uPA)并阻断纤溶酶原激活过程。GGACK可用于癌症和凝血相关疾病的相关研究[1]

GGACK (10-100nM) 处理经PMA刺激以高表达uPAR的U-937白血病细胞30分钟,随后加入荧光标记的HMW-uPA,GGACK可竞争性抑制HMW-uPA与细胞表面uPAR受体的结合[2]

实验参考方法

Cell experiment [1]:

Cell lines

U-937 cells (human monocyte-like leukemia cell line)

Preparation Method

Phorbol 12-myristate-13-acetate (PMA)-stimulated U-937 cells were used. For the competition flow cytometry assay, cells were pre-incubated on ice for 30 minutes with 10nM or 100nM of either GGACK-inactivated HMW-uPA (i-uPA) or a test compound. Subsequently, 1nM of Alexa Fluor 488-labeled active HMW-uPA was added and incubated with the cells for 30 minutes on ice. The samples were then washed, fixed, and analyzed by flow cytometry.

Reaction Conditions

10nM or 100nM; 30min pre-incubation on ice.

Applications

GGACK-inactivated HMW-uPA (i-uPA) potently antagonized the binding of Alexa Fluor 488-labeled active HMW-uPA to cell surface urokinase-type plasminogen activator receptors (uPAR). GGACK inhibited the fluorescent signal, demonstrating its strong efficacy as a competitive antagonist in the uPA:uPAR binding assay.

References:
[1] De Souza M, Matthews H, Lee JA, et al. Small molecule antagonists of the urokinase (uPA): urokinase receptor (uPAR) interaction with high reported potencies show only weak effects in cell-based competition assays employing the native uPAR ligand. Bioorg Med Chem. 2011 Apr 15;19(8):2549-56.

化学性质

Cas No. 65113-67-9 SDF
别名 精氨酸杂质
分子式 C14H25ClN6O5 分子量 392.84
溶解度 Soluble in DMSO 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.5456 mL 12.7278 mL 25.4557 mL
5 mM 509.1 μL 2.5456 mL 5.0911 mL
10 mM 254.6 μL 1.2728 mL 2.5456 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

Product Documents

Quality Control & SDS

View current batch: